methamphetamine has been researched along with Cardiotoxicity in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 5 (45.45) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Lu, J; Qiu, H; Wang, H; Yue, X; Zhang, C; Zhang, M; Zhao, X | 1 |
| Chen, LJ; Li, JH; Li, XW; Liu, JL; Liu, Y; Wang, Q; Xu, JT; Yang, JZ; Zhang, KK; Zhi, X | 1 |
| Bayrami, D; Jamali, Z; Salimi, A; Shabani, M | 1 |
| Gabriel, R; Kueh, SA; Looi, JL; Lund, M; Sutton, T; Wang, TKM | 1 |
| Chau, E; Elkayam, U; Ng, TM; Patel, SV; Reddy, PK; Yang, K | 1 |
| Adler, E; Alshawabkeh, L; Bhatia, HS; Dickson, SD; Greenberg, B; Lin, T; Mahmud, E; Nishimura, M; Thomas, IC; Tu, XM | 1 |
| Harms, BN; Kelly, A; Richards, JR; Turnipseed, SD | 1 |
| Bardo, MT; Crooks, PA; Dwoskin, LP; Lee, NR; Zheng, G | 1 |
| Han, E; Kwon, NJ | 1 |
| Janardhanan, R; Kannan, A | 1 |
| Bosch, X; Ortega-Paz, L; Pujol-López, M; Roqué, M | 1 |
1 review(s) available for methamphetamine and Cardiotoxicity
| Article | Year |
|---|---|
A commentary on the effects of methamphetamine and the status of methamphetamine abuse among youths in South Korea, Japan, and China.
Topics: Adolescent; Adolescent Behavior; Amphetamine-Related Disorders; Blood Pressure; Body Temperature; Cardiotoxicity; Central Nervous System Stimulants; China; Cognition Disorders; Dopamine Uptake Inhibitors; Humans; Japan; Methamphetamine; Republic of Korea; Wastewater | 2018 |
10 other study(ies) available for methamphetamine and Cardiotoxicity
| Article | Year |
|---|---|
New insight into methamphetamine-associated heart failure revealed by transcriptomic analyses: Circadian rhythm disorder.
Topics: Animals; ARNTL Transcription Factors; Cardiotoxicity; Chronobiology Disorders; Gene Regulatory Networks; Heart Failure; Methamphetamine; MicroRNAs; Rats; RNA, Long Noncoding; Transcriptome | 2022 |
Gut microbiota contribute to Methamphetamine-induced cardiotoxicity in mouse model.
Topics: Animals; Anti-Bacterial Agents; Cardiotoxicity; Gastrointestinal Microbiome; Male; Methamphetamine; Mice; Phosphatidylinositol 3-Kinases | 2023 |
Vanillic acid alleviates methamphetamine-induced mitochondrial toxicity in cardiac mitochondria via antioxidant activity and inhibition of MPT Pore opening: an in-vitro study.
Topics: Animals; Antioxidants; Cardiotoxicity; Glutathione; Lipid Peroxidation; Membrane Potential, Mitochondrial; Methamphetamine; Mitochondria; Oxidative Stress; Rats; Reactive Oxygen Species; Vanillic Acid | 2023 |
Poor outcomes in methamphetamine-associated cardiomyopathy-a growing health issue in New Zealand.
Topics: Adult; Cardiomyopathies; Cardiotoxicity; Central Nervous System Stimulants; Cohort Studies; Female; Heart Arrest; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Methamphetamine; New Zealand; Prognosis; Substance-Related Disorders | 2019 |
Characteristics of Methamphetamine-associated Cardiomyopathy and the Impact of Methamphetamine Use on Cardiac Dysfunction.
Topics: Administration, Intranasal; Adult; Amphetamine-Related Disorders; Cardiomyopathies; Cardiotoxicity; Case-Control Studies; Central Nervous System Stimulants; Echocardiography; Female; Humans; Male; Methamphetamine; Middle Aged; Smoking; Stroke Volume; Ventricular Dysfunction, Left | 2021 |
Methamphetamine-Associated Heart Failure Hospitalizations Across the United States: Geographic and Social Disparities.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphetamine-Related Disorders; Cardiotoxicity; Central Nervous System Stimulants; Cross-Sectional Studies; Databases, Factual; Female; Health Status Disparities; Heart Failure; Hospitalization; Humans; Inpatients; Male; Methamphetamine; Middle Aged; Prevalence; Risk Assessment; Risk Factors; Social Determinants of Health; Socioeconomic Factors; Time Factors; United States; Young Adult | 2021 |
Methamphetamine use and heart failure: Prevalence, risk factors, and predictors.
Topics: Adult; Biomarkers; California; Cardiotoxicity; Echocardiography; Female; Heart Failure; Humans; Logistic Models; Male; Methamphetamine; Middle Aged; Natriuretic Peptide, Brain; Prevalence; Retrospective Studies; Risk Factors; Stroke Volume; Trauma Centers; Troponin I; Ventricular Function, Left | 2018 |
New Scaffold for Lead Compounds to Treat Methamphetamine Use Disorders.
Topics: Administration, Oral; Amphetamine-Related Disorders; Animals; Cardiotoxicity; Disease Models, Animal; Dopamine; Ether-A-Go-Go Potassium Channels; Humans; Lobeline; Locomotion; Male; Methamphetamine; Molecular Structure; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Treatment Outcome; Vesicular Monoamine Transport Proteins | 2018 |
Methamphetamine Cardiotoxicity: Unique Presentation with Multiple Bi-Ventricular Thrombi.
Topics: Adult; Amphetamine-Related Disorders; Cardiotoxicity; Echocardiography; Heart Diseases; Heart Ventricles; Humans; Male; Methamphetamine; Pulmonary Embolism; Radiography; Thrombosis | 2016 |
Severe Cardiac Complications of Shabu Use: An Emerging Drug in Europe.
Topics: Adult; Cardiotoxicity; Central Nervous System Stimulants; Female; Heart Diseases; Humans; Incidence; Male; Methamphetamine; Middle Aged; Philippines; Risk Factors; Survival Rate; Young Adult | 2017 |